1978 related articles for article (PubMed ID: 18840035)
1. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
[TBL] [Abstract][Full Text] [Related]
2. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy.
Wade RL; Kindermann SL; Hou Q; Thase ME
J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461
[TBL] [Abstract][Full Text] [Related]
4. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
Khandker RK; Kruzikas DT; McLaughlin TP
J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.
Vlahiotis A; Devine ST; Eichholz J; Kautzner A
J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545
[TBL] [Abstract][Full Text] [Related]
7. Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study.
Dennehy EB; Robinson RL; Stephenson JJ; Faries D; Grabner M; Palli SR; Stauffer VL; Marangell LB
Curr Med Res Opin; 2015 Jun; 31(6):1165-77. PubMed ID: 25879140
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
9. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders.
Stein MB; Cantrell CR; Sokol MC; Eaddy MT; Shah MB
Psychiatr Serv; 2006 May; 57(5):673-80. PubMed ID: 16675762
[TBL] [Abstract][Full Text] [Related]
12. Differences in total medical costs across the SSRIs for the treatment of depression and anxiety.
Sheehan DV; Eaddy MT; Shah MB; Mauch RP
Am J Manag Care; 2005 Oct; 11(12 Suppl):S354-61. PubMed ID: 16236017
[TBL] [Abstract][Full Text] [Related]
13. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B
J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
[No Abstract] [Full Text] [Related]
14. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.
Cantrell CR; Eaddy MT; Shah MB; Regan TS; Sokol MC
Med Care; 2006 Apr; 44(4):300-3. PubMed ID: 16565629
[TBL] [Abstract][Full Text] [Related]
15. A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder.
Chollet J; Saragoussi D; Clay E; François C
Value Health; 2013 Dec; 16(8):1133-9. PubMed ID: 24326166
[TBL] [Abstract][Full Text] [Related]
16. Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).
Keyloun KR; Hansen RN; Hepp Z; Gillard P; Thase ME; Devine EB
CNS Drugs; 2017 May; 31(5):421-432. PubMed ID: 28378157
[TBL] [Abstract][Full Text] [Related]
17. Prescription patterns of antidepressants: findings from a US claims database.
Milea D; Verpillat P; Guelfucci F; Toumi M; Lamure M
Curr Med Res Opin; 2010 Jun; 26(6):1343-53. PubMed ID: 20373875
[TBL] [Abstract][Full Text] [Related]
18. Real-World Health Plan Data Analysis: Key Trends in Medication Adherence and Overall Costs in Patients with HIV.
Kangethe A; Polson M; Lord TC; Evangelatos T; Oglesby A
J Manag Care Spec Pharm; 2019 Jan; 25(1):88-93. PubMed ID: 30589631
[TBL] [Abstract][Full Text] [Related]
19. Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy--results from a managed care administrative claims database.
Eaddy MT; Druss BG; Sarnes MW; Regan TS; Frankum LE
J Manag Care Pharm; 2005 Mar; 11(2):145-50. PubMed ID: 15766321
[TBL] [Abstract][Full Text] [Related]
20. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
